Surgery
Volume 148, Issue 4 , Pages 613-617 , October 2010

Industrial relations with academic health care and professional medical associations: What's all the fuss? Who cares anyway?

  • William Turnipseed, MD

      Affiliations

    • Corresponding Author InformationReprint requests: William Turnipseed, MD, Division of Vascular Surgery, UW Hospital and Clinics, 600 Highland Avenue, Madison, WI 53792.

,Accepted 15 July 2010.

References 

  1. Landefeld CS, Steinman MA. The neurontin legacy-marketing through misinformation and manipulation. N Engl J Med. 2009;360:103–106
  2. Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006;145:284–293
  3. Pringle E. Medtronic's medical device troubles far from over, 2006. Available from: http://www.lawyerandsettlements.com/articles/00251/medtronics_legal.html.
  4. Meier B, Saul S. Marketing of Vioxx: how Merck played game of catch-up. New York Times, February 11, 2005; A.1.
  5. Schwarze ML. Conflict of interest with industry and the challenges for surgical education. J Am Coll Surg. 2009;209:766–767
  6. Blumenthal D, Gluck M, Louis KS, Stoto MA, Wise D. University-industry research relationships in biotechnology: implications for the university. Science. 1986;232:1361–1366
  7. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with pharmaceutical industry—self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891–1900
  8. Elliott C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Cent Rep. 2004;34:18–23
  9. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454–465
  10. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290:252–255
  11. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA. 2000;283:373–380
  12. Steinbrook R. Physician-industry relations—will fewer gifts make a difference?. N Engl J Med. 2009;360:557–559
  13. Schafer A. Biomedical conflicts of interest: a defence of the sequestration thesis—learning from the cases of Nancy Olivieri and David Healy. J Med Ethics. 2004;30:8–24
  14. American Medical Association. E-8.061 Ethical guidelines for gifts to physicians from industry, Updated 2004. Available from: http://www.ama-assn.rog/ama1/pub/upload/mm/369/e-8_061.pdf.
  15. Pharmaceutical Research and Manufacturers of America. PhRMA Code on interactions with healthcare professionals: 2002. Available from: http://www.phrma.org/files/PhRMA%20Code.pdf.
  16. US Department of Health and Human Service, Office of Inspector General. Compliance program guidance for pharmaceutical manufacturers. Fed Reg. 2003;68:23731–23743document 03–10949
  17. Chimonas S, Rothman DJ. New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation. Health Aff. 2005;24:949–960
  18. Association of American Medical Colleges Task Force on Financial Conflicts of Interest in Clinical Research. Protection subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research, 2002. Available from: http://www.aamc.org/research/coi/2002coireport.pdf.
  19. Steinbrook R. Controlling conflict of interest—proposals from the institute of medicine. N Engl J Med. 2009;360:2160–2163
  20. Relman AS. Industry support of medical education. JAMA. 2008;300:1071–1073
  21. Nakayama DK, Bozeman AP. Industry support of graduate medical education in surgery. Am Surg. 2009;75:395–400
  22. Steinbrook R. Financial support of continuing medical education. JAMA. 2008;299:1060–1062
  23. Rothman DJ. Academic medical centers and financial conflicts of interest. JAMA. 2008;299:695–697
  24. Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, et al. Health industry practice that create conflicts of interests: a policy proposal for academic medical centers. JAMA. 2006;295:429–433
  25. Rothman DJ, McDonald WJ, Berkowitz CD, Chimonas SC, DeAngelis CD, Hale RW, et al. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA. 2009;301:1367–1372
  26. Rothman DJ, Chimonas S. New developments in managing physician-industry relationships. JAMA. 2008;300:1067–1069
  27. Stossel TP. Regulating academic-industry research relationship-solving problems or stifling progress. N Engl J Med. 2005;353:1060–1065
  28. Stossel TP. Regulation of financial conflicts of interest in medical practice and medical research. A damaging solution in search of a problem. Perspect Biol Med. 2007;50:54–71
  29. Stossel TP. A biopsy of financial conflicts of interest in medicine. Surgery. 2008;143:193–198
  30. Cain DM, Detsky AS. Everyone's a little bit biased (even physicians). JAMA. 2008;299:2893–2895
  31. Foster RS. Conflicts of interest: recognition, disclosure, and management. J Am Coll Surg. 2003;196:505–517
  32. Steinbrook R. Online disclosure of physician-industry relationships. N Engl J Med. 2009;360:325–327
  33. Cain DM, Loewenstein G, Moore DA. The dirt on coming clean: perverse effects of disclosing conflicts of interest. J Legal Study. 2005;34:1–25
  34. Angell M. The truth about drug companies: how they deceive us and what to do about it. New York: Random House; 2004;

PII: S0039-6060(10)00394-6

doi: 10.1016/j.surg.2010.07.026

Surgery
Volume 148, Issue 4 , Pages 613-617 , October 2010

Article Tools